Burt A. Adelman - 15 Mar 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact for Burt Adelman
Issuer symbol
VERV
Transactions as of
15 Mar 2022
Net transactions value
+$85,535
Form type
4
Filing time
17 Mar 2022, 07:58:16 UTC
Previous filing
06 Dec 2021
Next filing
13 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Purchase $85,535 +4,000 +85% $21.38 8,700 15 Mar 2022 Burt A Adelman 2002 Trust F1
holding VERV Common Stock 409,626 15 Mar 2022 The Burt A. Adelman 2021 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $21.38 to $21.43 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.